From glucose lowering agents to disease/diabetes modifying drugs: a “SIMPLE” approach for the treatment of type 2 diabetes

During the last decade we experienced a surge in the number of glucose lowering agents that can be used to treat patients with type 2 diabetes. Especially important are the discoveries that sodium glucose co-transporter type 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cardiovasc Diabetol
Main Authors: Mosenzon, Ofri, Del Prato, Stefano, Schechter, Meir, Leiter, Lawrence A., Ceriello, Antonio, DeFronzo, Ralph A., Raz, Itamar
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2021
Teme:
Review
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8082901/
https://ncbi.nlm.nih.gov/pubmed/33910583
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-021-01281-y
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki